This inventor holds 3 USPTO granted patents and 11 published patent applications. Top assignees: Viridian Therapeutics, Inc., Hercules Capital, Inc., as Agent. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Innovations by Inventor Yang Zhao
Introduction
Yang Zhao is an accomplished inventor based in Waltham, MA (US). He has made significant contributions to the field of medical treatments, particularly in addressing thyroid eye disease. With a total of 3 patents to his name, Zhao's work is recognized for its innovative approaches and potential impact on patient care.
Latest Patents
One of Yang Zhao's latest patents is titled "Compositions and Methods for Treatment of Thyroid Eye Disease." This patent focuses on the development of antibodies and compositions that target the Insulin-Like Growth Factor-1 Receptor (IGF-1R). The methods described aim to treat or reduce the severity of thyroid eye disease (TED) by inhibiting the activity of IGF-1R. The innovative use of anti-IGF-1R antibodies presents a promising avenue for those suffering from this condition.
Career Highlights
Throughout his career, Yang Zhao has worked with notable companies such as Viridian Therapeutics, Inc. and Hercules Capital, Inc., where he served as an agent. His experience in these organizations has contributed to his expertise in developing therapeutic solutions and advancing medical research.
Collaborations
Yang Zhao has collaborated with professionals in his field, including Vahe Bedian and Angela She. These partnerships have likely enhanced his research and development efforts, leading to impactful innovations.
Conclusion
In summary, Yang Zhao is a notable inventor whose work in the treatment of thyroid eye disease showcases his commitment to advancing medical science. His innovative patents and collaborations reflect his dedication to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile